ToxSci Advance Access originally published online on January 12, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 78, 248-257 (2004)
Toxicological Sciences vol. 78 no. 2 © Society of Toxicology; all rights reserved.
A Novel Effect of Dioxin: Exposure during Pregnancy Severely Impairs Mammary Gland Differentiation
,
,1
* Department of Pharmaceutical Sciences, Washington State University, Pullman, Washington 99164; Reproductive Toxicology Division, US EPA, ORD/NHEERL, Research Triangle Park, North Carolina 27711; Department of Veterinary Clinical Sciences and Center for Reproductive Biology, Washington State University Pullman, Washington 99164
Received October 14, 2003; accepted December 16, 2003
Many ligands for the aryl hydrocarbon receptor (AhR) are considered endocrine disruptors and carcinogens, and assessment of adverse health effects in humans exposed to such chemicals has often focused on malignancies, including breast cancer. Mammary tissue contains the AhR, and inappropriate activation of the AhR during fetal development causes defects in mammary development that persist into adulthood. However, it is not known whether the extensive differentiation of mammary tissue that occurs during pregnancy is also sensitive to disruption by AhR activation. To examine this, we exposed pregnant C57Bl/6 mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on days 0, 7, and 14 of pregnancy. Examination of mammary glands on days 9, 12, and 17 of pregnancy and on the day of parturition showed severe defects in development, including stunted growth, decreased branching, and poor formation of lobular alveolar structures. This impaired differentiation was biologically significant, as expression of whey acidic protein in the gland was suppressed, and all pups born to TCDD-treated dams died within 24 h of birth. Analysis of circulating progesterone, prolactin, and estradiol suggest that hormone production was slightly impaired by inappropriate activation of the AhR. However, hormone levels were affected only very late in pregnancy. Given that the observed defects in gland development preceded these hormonal effects, altered hormone levels are an unlikely mechanistic explanation for impaired mammary development. This novel finding that AhR activation during pregnancy disrupts mammary gland differentiation raises questions about the susceptibility of mammary tissue to direct injury by endocrine disrupting agents and the potential for AhR-mediated signaling to adversely affect lactation and breast tissue development in human populations.
Key Words: TCDD; mammary; pregnancy; prolactin; estrogen; progesterone.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. V. Martin, J. N. Lester, N. Voulvoulis, and A. R. Boobis Human Health and Endocrine Disruption: A Simple Multicriteria Framework for the Qualitative Assessment of End Point Specific Risks in a Context of Scientific Uncertainty Toxicol. Sci., August 1, 2007; 98(2): 332 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Bemis, N. F. Alejandro, D. A. Nazarenko, A. I. Brooks, R. B. Baggs, and T. A. Gasiewicz TCDD-Induced Alterations in Gene Expression Profiles of the Developing Mouse Paw Do Not Influence Morphological Differentiation of This Potential Target Tissue Toxicol. Sci., January 1, 2007; 95(1): 240 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lee, J. R. Hutson, V. K.-F. Tzau, and D. S. Riddick Regulation of Constitutive Mouse Hepatic Cytochromes P450 and Growth Hormone Signaling Components by 3-Methylcholanthrene Drug Metab. Dispos., September 1, 2006; 34(9): 1530 - 1538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dragin, T. P. Dalton, M. L. Miller, H. G. Shertzer, and D. W. Nebert For Dioxin-induced Birth Defects, Mouse or Human CYP1A2 in Maternal Liver Protects whereas Mouse CYP1A1 and CYP1B1 Are Inconsequential J. Biol. Chem., July 7, 2006; 281(27): 18591 - 18600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Fenton Endocrine-Disrupting Compounds and Mammary Gland Development: Early Exposure and Later Life Consequences Endocrinology, June 1, 2006; 147(6): s18 - s24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Hockings, P. A. Thorne, M. Q. Kemp, S. S. Morgan, O. Selmin, and D. F. Romagnolo The Ligand Status of the Aromatic Hydrocarbon Receptor Modulates Transcriptional Activation of BRCA-1 Promoter by Estrogen Cancer Res., February 15, 2006; 66(4): 2224 - 2232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Curran, K. A. Miller, T. P. Dalton, C. V. Vorhees, M. L. Miller, H. G. Shertzer, and D. W. Nebert Genetic Differences in Lethality of Newborn Mice Treated In Utero with Coplanar versus Non-Coplanar Hexabromobiphenyl Toxicol. Sci., February 1, 2006; 89(2): 454 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rayner, R. R. Enoch, and S. E. Fenton Adverse Effects of Prenatal Exposure to Atrazine During a Critical Period of Mammary Gland Growth Toxicol. Sci., September 1, 2005; 87(1): 255 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Emond, L. S. Birnbaum, and M. J. DeVito Physiologically Based Pharmacokinetic Model for Developmental Exposures to TCDD in the Rat Toxicol. Sci., July 1, 2004; 80(1): 115 - 133. [Abstract] [Full Text] [PDF]
|
|